NDC 49702-264

Apretude

Cabotegravir

Apretude is a Kit in the Human Prescription Drug category. It is labeled and distributed by Viiv Healthcare Company. The primary component is .

Product ID49702-264_0b6dc5c3-42da-49eb-afe5-8e765fa4680e
NDC49702-264
Product TypeHuman Prescription Drug
Proprietary NameApretude
Generic NameCabotegravir
Dosage FormKit
Marketing Start Date2021-12-20
Marketing CategoryNDA /
Application NumberNDA215499
Labeler NameViiV Healthcare Company
Active Ingredient Strength0
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 49702-264-23

1 KIT in 1 CARTON (49702-264-23) * 3 mL in 1 VIAL (49702-238-03)
Marketing Start Date2021-12-20
NDC Exclude FlagN
Sample Package?N

Drug Details


Trademark Results [Apretude]

Mark Image

Registration | Serial
Company
Trademark
Application Date
APRETUDE
APRETUDE
88680774 not registered Live/Pending
Glaxo Group Limited
2019-11-05
APRETUDE
APRETUDE
85775770 5056992 Live/Registered
Glaxo Group Limited
2012-11-09

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.